Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Variability: Analysis01:11

Variability: Analysis

137
Measures of variability are statistical metrics that reveal the dispersion pattern within a dataset. They are pivotal in biostatistics, providing insights into the heterogeneity within health and biological data. Variability signifies the degree to which data points diverge from one another, helping researchers understand the potential range of values and associated uncertainty within the data.
The range is a simple measure of variability, indicating the difference between the highest and...
137
Data Validation01:15

Data Validation

160
Method validation is a crucial process in analytical chemistry designed to confirm that a given method consistently produces reliable and high-quality results. This process is essential when a method is applied to different sample matrices or when procedural modifications are made, ensuring that the results meet acceptable standards across various applications.
Key parameters for method validation include:
160
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

4.3K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.3K
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

252
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
252

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Discovery of a mutation-containing circRNA in polyglutamine disease through systematic analysis of RNAs with CAG repeats.

RNA biology·2026
Same author

Comparative evaluation of dose accumulation strategies in the clinical reirradiation setting.

Physics and imaging in radiation oncology·2026
Same author

Automated Referral Prompts Reveal Lack of Equitable Access to Care in Patients With Aortic Stenosis.

Structural heart : the journal of the Heart Team·2026
Same author

Treatment planning for lung cancer reirradiation accounting for previously delivered dose.

Physics and imaging in radiation oncology·2026
Same author

Impact of Improvisation Training on Medical Students' Experience with Medical Communication in Clinical Rotations-A Single-Center Mixed-Methods Study.

Medical science educator·2026
Same author

Robust organ mapped dose: using multiple image registrations to identify deformation uncertainty in radiation dose mapping.

Physics in medicine and biology·2026
Same journal

Impact of Information Leakage in Platform Trials With Survival Endpoints on Type I Error Control.

Pharmaceutical statistics·2026
Same journal

Harmonic Fowlkes-Mallows Index for Medical Diagnostics Tests and Optimal Cut-Off Point Selection of Binary Diseases.

Pharmaceutical statistics·2026
Same journal

Early Phase Dose-Finding Designs for CAR-T Cell Therapies.

Pharmaceutical statistics·2026
Same journal

Optimizing Randomization Ratios in Clinical Trials With Survival Endpoints.

Pharmaceutical statistics·2026
Same journal

CUI-MET: A Clinical Utility Index Based Analysis and Decision Framework for Dose Optimization in Multiple-Dose, Multiple-Outcome Randomized Trials.

Pharmaceutical statistics·2026
Same journal

Will the Pharmaceutical Industry Need Statisticians in an AI World?

Pharmaceutical statistics·2026
See all related articles
  1. Home
  3. Potency Assay Variability Estimation In Practice.
  1. Home
  3. Potency Assay Variability Estimation In Practice.

Related Experiment Video

Author Spotlight: Biological Standardization to Ensure Reproducibility and Harmonization in Research
04:50

Author Spotlight: Biological Standardization to Ensure Reproducibility and Harmonization in Research

Published on: August 4, 2023

1.0K

Potency Assay Variability Estimation in Practice.

Hang Li1, Tomasz M Witkos2, Scott Umlauf3

  • 1Data Science & Modelling, Biopharmaceutical Development, AstraZeneca, Gaithersburg, Maryland, USA.

Pharmaceutical Statistics
|July 9, 2024

View abstract on PubMed

Summary
This summary is machine-generated.

This study addresses variability in biologic drug potency bioassays, crucial for quality assessment. It proposes a statistical algorithm to estimate variability and out-of-specification rates for manufacturing.

Keywords:
CMC statisticsbioassaylinear mixed modelmethod variabilitypotency

More Related Videos

Viability Assays for Cells in Culture
12:03

Viability Assays for Cells in Culture

Published on: January 20, 2014

46.2K
A Small-Scale Setup for Algal Toxicity Testing of Nanomaterials and Other Difficult Substances
08:18

A Small-Scale Setup for Algal Toxicity Testing of Nanomaterials and Other Difficult Substances

Published on: October 10, 2020

5.7K

Related Experiment Videos

Author Spotlight: Biological Standardization to Ensure Reproducibility and Harmonization in Research
04:50

Author Spotlight: Biological Standardization to Ensure Reproducibility and Harmonization in Research

Published on: August 4, 2023

1.0K
Viability Assays for Cells in Culture
12:03

Viability Assays for Cells in Culture

Published on: January 20, 2014

46.2K
A Small-Scale Setup for Algal Toxicity Testing of Nanomaterials and Other Difficult Substances
08:18

A Small-Scale Setup for Algal Toxicity Testing of Nanomaterials and Other Difficult Substances

Published on: October 10, 2020

5.7K

Area of Science:

  • Biopharmaceutical quality control
  • Analytical chemistry
  • Biotechnology

Background:

  • Potency testing is vital for biologic drug quality assessment during development.
  • Bioassays exhibit higher variability than physicochemical methods due to operational and biological factors.

Purpose of the Study:

  • To discuss sources of bioassay variability and statistical estimation methods.
  • To propose an algorithm for estimating reportable result variability and out-of-specification (OOS) rates.

Main Methods:

  • Statistical analysis of bioassay variability sources.
  • Development and application of a novel algorithm for variability estimation.
  • Numerical experiments across multiple assay formats.

Main Results:

  • Identification and discussion of key factors contributing to bioassay variability.
  • Empirical distribution of bioassay variability elucidated through numerical experiments.
  • Algorithm provides estimates for variability based on runs and OOS rates.

Conclusions:

  • Understanding and statistically estimating bioassay variability is critical for reliable biologic manufacturing.
  • The proposed algorithm aids in assessing the impact of variability on product quality and OOS rates.
  • This work contributes to robust quality control strategies in the biopharmaceutical industry.